These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36604804)

  • 1. Opportunity in nanomedicine to counter the challenges of current drug delivery approaches used for the treatment of malaria: a review.
    Rajwar TK; Pradhan D; Halder J; Rai VK; Kar B; Ghosh G; Rath G
    J Drug Target; 2023 Apr; 31(4):354-368. PubMed ID: 36604804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-facilitated drug delivery strategies in the treatment of plasmodium infection.
    Puttappa N; Kumar RS; Kuppusamy G; Radhakrishnan A
    Acta Trop; 2019 Jul; 195():103-114. PubMed ID: 31039335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in use of silver nanoparticles as antimalarial agents.
    Rai M; Ingle AP; Paralikar P; Gupta I; Medici S; Santos CA
    Int J Pharm; 2017 Jun; 526(1-2):254-270. PubMed ID: 28450172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicines for Malaria Chemotherapy: Encapsulation vs. Polymer Therapeutics.
    Mvango S; Matshe WMR; Balogun AO; Pilcher LA; Balogun MO
    Pharm Res; 2018 Oct; 35(12):237. PubMed ID: 30324329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria Surveillance - United States, 2017.
    Mace KE; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2021 Mar; 70(2):1-35. PubMed ID: 33735166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into molecular diagnosis for antimalarial drug resistance of Plasmodium falciparum parasites: A review.
    Zhong A; Zhang H; Li J
    Acta Trop; 2023 May; 241():106870. PubMed ID: 36849091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug targets for resistant malaria: Historic to future perspectives.
    Kumar S; Bhardwaj TR; Prasad DN; Singh RK
    Biomed Pharmacother; 2018 Aug; 104():8-27. PubMed ID: 29758416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized feasibility trial comparing four antimalarial drug regimens to induce
    Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
    Elife; 2018 Feb; 7():. PubMed ID: 29482720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanobiotechnological modules as molecular target tracker for the treatment and prevention of malaria: options and opportunity.
    Anamika J; Nikhar V; Laxmikant G; Priya S; Sonal V; Vyas SP
    Drug Deliv Transl Res; 2020 Aug; 10(4):1095-1110. PubMed ID: 32378173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Nanotechnologies for the Effective Therapy of Malaria Using Plant-Based Medicines.
    Oga EF; Singh KK
    Curr Pharm Des; 2016; 22(27):4232-46. PubMed ID: 27262326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria Surveillance - United States, 2015.
    Mace KE; Arguin PM; Tan KR
    MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria Surveillance - United States, 2016.
    Mace KE; Arguin PM; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2019 May; 68(5):1-35. PubMed ID: 31099769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyamidoamine nanoparticles as nanocarriers for the drug delivery to malaria parasite stages in the mosquito vector.
    Urbán P; Ranucci E; Fernàndez-Busquets X
    Nanomedicine (Lond); 2015 Nov; 10(22):3401-14. PubMed ID: 26582279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Structural Chemistry Perspective on the Antimalarial Properties of Thiosemicarbazone Metal Complexes.
    Summers KL
    Mini Rev Med Chem; 2019; 19(7):569-590. PubMed ID: 30324878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid nanocarriers and molecular targets for malaria chemotherapy.
    Jain K; Sood S; Gowthamarajan K
    Curr Drug Targets; 2014 Mar; 15(3):292-312. PubMed ID: 24160438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combating multidrug-resistant Plasmodium falciparum malaria.
    Thu AM; Phyo AP; Landier J; Parker DM; Nosten FH
    FEBS J; 2017 Aug; 284(16):2569-2578. PubMed ID: 28580606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.